Provided by Tiger Trade Technology Pte. Ltd.

CMS

10.880
-0.300-2.68%
Volume:10.66M
Turnover:115.96M
Market Cap:26.47B
PE:15.14
High:11.180
Open:11.180
Low:10.740
Close:11.180
52wk High:15.195
52wk Low:9.354
Shares:2.43B
HK Float Shares:2.43B
Volume Ratio:2.43
T/O Rate:0.44%
Dividend:0.34
Dividend Rate:3.16%
EPS(LYR):0.719
ROE:8.42%
ROA:5.62%
PB:1.26
PE(LYR):15.14
PS:2.60

Loading ...

CMS Allocates HK$5.58 Million for Share Buyback on June 1

Stock News
·
Jun 01

CMS Cuts Outstanding Shares by 1.02 Million in May; Maintains Public Float Compliance

Bulletin Express
·
Jun 01

CMS Allocates Approximately HK$10.81 Million for Share Buyback on May 29

Stock News
·
May 29

China Medical System Gets China Trial Approval for Crohn's, Colitis Drug

MT Newswires Live
·
May 26

CMS Receives Regulatory Clearance for Clinical Trials of Novel TYK2 Inhibitor in Ulcerative Colitis and Crohn's Disease

Stock News
·
May 26

China Medical System Holdings - CMS-D001 Granted Drug Clinical Trial Approval by Nmpa on 25 May 2026

THOMSON REUTERS
·
May 26

AI Frenzy Shifts from Hardware to Applications, Musk-Related Concepts Gain Traction

Stock News
·
May 07

CMS (867.HK/8a8.SG) Signed an Exclusive Commercialization and Supply Agreement for Marketed Originator Intravenous Iron Products Monofer® and Cosmofer®

THOMSON REUTERS
·
Apr 27

China Medical System Holdings - Pharmacosmos to Manufacture and Supply Monofer and Cosmofer for Fifteen Years

THOMSON REUTERS
·
Apr 27

China Medical System Holdings: Nda for Mg-K10 for Seasonal Allergic Rhinitis Accepted by Nmpa in China on April 23, 2026

THOMSON REUTERS
·
Apr 23

CMS Secures NMPA Nod to Review MG-K10 NDA for Once-Monthly Treatment of Seasonal Allergic Rhinitis

Bulletin Express
·
Apr 23

China Medical System shareholders approved RMB 0.1366 final dividend per share

Reuters
·
Apr 23

CMS Announces NMPA Acceptance of New Drug Application for MG-K10 in Seasonal Allergic Rhinitis

Stock News
·
Apr 23

China Medical System says China regulator accepts MG-K10 allergic rhinitis NDA

Reuters
·
Apr 23

China Medical System - New Drug Application for Seasonal Allergic Rhinitis Indication of Class 1 Innovative Drug Mg-K10 Accepted in China

THOMSON REUTERS
·
Apr 23

CMS Sets 23 Apr 2026 AGM; Proposes RMB0.1366 Final Dividend, 20% Issue Mandate and 10% Buy-back Authority

Bulletin Express
·
Apr 01

China Medical System Holdings announces annual general meeting notice

Reuters
·
Apr 01

中国医疗系统 2025 年度业绩:收入达 82.121 亿元,研发投入大幅攀升

Bulletin Express
·
Apr 01

China Medical System publishes 2025 annual report

Reuters
·
Apr 01

CMS Affirms Stable Capital Structure in March 2026 Monthly Return; Issued Shares Hold at 2.44 B

Bulletin Express
·
Mar 31